Cancer vaccines: platforms and current progress.

Mol Biomed · 2025 · PMC11717780 · PMID 39789208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

The GP2 cancer vaccine, targeting HER2/neu and designed for breast cancer, exhibited a notable trend toward improved DFS among HER2-positive patients post-standard treatment.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.